Search

everythinglearnresearchcommunity

for

Search:↓

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Hair, teeth, and mammary glands develop similarly at first but use different genes later.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Smoking is linked to more hair loss and premature graying compared to nonsmokers.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Many skin patients also have mental health issues, and doctors should treat both together.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Finasteride effectively treats baldness but may cause sexual side effects.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.

Athletes need effective management of skin disorders for their performance and well-being.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.